Burning Rock (Nasdaq:BNR) announced today that the FDA granted breakthrough device designation to its OverC blood test. Irvine, California-based Burning Rock developed OverC as a multi-cancer detection blood test (MCDBT). It designed the test to detect cancer types including esophageal, liver, lung, ovarian and pancreatic cancers. Adults of either sex, aged 50-75 years old, at […]